Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Small Cap

Small Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks
  • Small Cap

Recap of Monday’s Biotech Catalysts – End of the Day Summary

By Ragothaman Srinivasan
July 18, 6:07 PM
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

ABBV

Read More
3 minute read
  • Cannabis
  • Cryptocurrency
  • Eurozone
  • Global
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Not Much Left To Squeeze: Investment Scam JuicyFields Collapses, Bilking Thousands Of Investors

By Nicolas Jose Rodriguez
July 18, 5:47 PM
JuicyFields, a pyramid scheme for cannabis investment that guaranteed its clients returns of up to 66% in just three months, froze cash withdrawals, removed their profiles from social media networks and those responsible disappeared without a trace,

ACB

Read More
1 minute read
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Codexis Shares Slide On CEO Transition

By Akanksha Bakshi
July 18, 4:52 PM
Codexis, Inc. (NASDAQ:CDXS) has appointed Dr. Stephen Dilly, Board member, and biotechnology veteran, as President and CEO, effective August 9,…

CDXS

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Bitcoin- And Ethereum-Related Stock Applied Blockchain Is Surging After Hours

By Adam Eckert
July 18, 4:19 PM
Applied Blockchain Inc (NASDAQ: APLD) shares are trading higher in Monday's after-hours session after the company announced it secured a five-year hosting contract with Marathon Digital Holdings Inc (NASDAQ:

APLD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

Here’s How Benchmark Sees AMC, Imax Perform In Upcoming Quarterly Results

By Anusuya Lahiri
July 18, 3:41 PM
Benchmark analyst Mike Hickey offered his take on two Entertainment & Digital Media stocks in the post-pandemic world ahead of their quarterly releases.

AMC

Read More
2 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

Needham Projects Roku’s Data Revenue Upside

By Anusuya Lahiri
July 18, 3:36 PM
Needham analyst Laura Martin reiterated a Buy on Roku, Inc (NASDAQ:ROKU) with a price target of $205. Near term, she did not believe…

ROKU

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Small Cap

HC Wainwright Is Bullish On DICE Therapeutics – Read Why

By Vandana Singh
July 18, 3:31 PM
H.C. Wainwright analyst Emily Bodnar initiated coverage on DICE Therapeutics Inc (NASDAQ:DICE) with a Buy rating and a price target of $40 (150%…

AMGN

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

HC Wainwright Initiates Coverage On This Nanocrystals Stock

By Vandana Singh
July 18, 3:05 PM
H.C. Wainwright initiated coverage on Clene Inc (NASDAQ:CLNN) with a Buy rating and a $16 price target.  Clene is focused on the…

CLNN

Read More
2 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap

U.S. Stocks Turn Lower; Crude Oil Settles Back Above This Level

By Lisa Levin
July 18, 2:54 PM
U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping around 80 points on Monday.

ADN

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Small Cap

SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside

By Vandana Singh
July 18, 2:46 PM
SVB Leerink initiated coverage on Nkarta Inc (NASDAQ:NKTX) with an Outperform rating and a price target of $30 (117% implied upside). The…

NKTX

Posts pagination

Previous 1 … 1,049 1,050 1,051 … 1,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service